Miracle-dz/UniFAR-FTUs huggingface dataset:
Fertility Preservation for Breast Cancer Patients

Breast cancer is the most common neoplasm in women and accounts for 26% (182,460) of all new cancer cases among women. With the use of screening mammography and advancement in other diagnostic modalities, many cases of breast cancer now can be diagnosed and treated at early stages of the disease. Unfortunately, adjuvant chemotherapy regimens commonly used in the treatment of breast cancer may cause premature ovarian failure due to their cytotoxic effects on the germ cells in the ovary. Therefore preservation of fertility in breast cancer survivors at reproductive age has become an important quality of life issue. Fertility preservation is a recently emerged ﬁeld of reproductive medicine that may help protect the reproductive capability of the cancer survivors and allow them to have children in the future. Embryo freezing is the most established fertility preservation strategy. But conventional ovarian stimulation protocols are contraindicated in breast cancer patients because of the rise of estrogen and its metabolites to supraphysiological levels. Recently developed ovarian stimulation protocols with aromatase inhibitor letrozole and tamoxifen appear to provide a safe stimulation with endogenous estrogen levels comparable with those achieved in the natural cycle. Oocyte freezing can be considered in single women and in those who do not wish donor sperm. Ovarian tissue freezing could also be an option in breast cancer patients who do not wish or have a time for an in vitro fertilization cycle, which requires 10 to 14 days of ovarian stimulation.
Approximation of convex bodies by multiple objective optimization and an application in reachable sets

Abstract In this paper, we focus on approximating convex compact bodies. For a convex body described as the feasible set in objective space of a multiple objective programme, we show that finding it is equivalent to finding the non-dominated set of a multiple objective programme. This equivalence implies that convex bodies can be approximated using multiple objective optimization algorithms. Therefore, we propose a revised outer approximation algorithm for convex multiple objective programming problems to approximate convex bodies. Finally, we apply the algorithm to solve reachable sets of control systems and use numerical examples to show the effectiveness of the algorithm.
Luminescence methodology to determine grain-boundary, grain-interior, and surface recombination in thin-film solar cells

We determine the grain-boundary (GB) recombination velocity, S G B, and grain-interior (GI) lifetime, τ G I, parameters in superstrate CdS/CdTe thin-film solar cell technology by combining cathodoluminescence (CL) spectrum imaging and time-resolved photoluminescence (TRPL) measurements. We consider critical device formation stages, including after CdTe deposition, CdCl2 treatment, and Cu diffusion. CL image analysis methods extract GB and GI intensities and grain size for hundreds of grains per sample. Concurrently, a three-dimensional CL model is developed to simulate the GI intensity as a function of τ G I, S G B, grain size, and the surface recombination velocity, S surf. TRPL measurements provide an estimate of S surf for the CL model. A fit of GI intensity vs. grain size data with the CL model gives a self-consistent and representative set of S G B and τ G I values for the samples: S G B ( τ G I ) = 2.6 × 106 cm/s (68–250 ps), S G B ( τ G I ) = 4.1 × 105 cm/s (1.5–3.3 ns), and S G B ( τ G I ) = 5.5 × 105 cm/s (1.0–3.8 ns) for as-deposited, CdCl2-treated, and CdCl2- and Cu-treated samples, respectively. Thus, we find that the CdCl2 treatment both helps to passivate GBs and significantly increase the GI lifetime. Subsequent Cu diffusion increases GB recombination slightly and has nuanced effects on the GI lifetime. Finally, as a partial check on the S G B and τ G I values, they are input to a Sentaurus device model, and the simulated performance is compared to the measured performance. The methodology developed here can be applied broadly to CdTe and CdSeTe thin-film technology and to other thin-film solar cell materials including Cu(In1-xGax)Se2, Cu2ZnSnS4, and perovskites.We determine the grain-boundary (GB) recombination velocity, S G B, and grain-interior (GI) lifetime, τ G I, parameters in superstrate CdS/CdTe thin-film solar cell technology by combining cathodoluminescence (CL) spectrum imaging and time-resolved photoluminescence (TRPL) measurements. We consider critical device formation stages, including after CdTe deposition, CdCl2 treatment, and Cu diffusion. CL image analysis methods extract GB and GI intensities and grain size for hundreds of grains per sample. Concurrently, a three-dimensional CL model is developed to simulate the GI intensity as a function of τ G I, S G B, grain size, and the surface recombination velocity, S surf. TRPL measurements provide an estimate of S surf for the CL model. A fit of GI intensity vs. grain size data with the CL model gives a self-consistent and representative set of S G B and τ G I values for the samples: S G B ( τ G I ) = 2.6 × 106 cm/s (68–250 ps), S G B ( τ G I ) .
Aging and Sleep: Physiology and Pathophysiology

Aging effects on sleep are important to consider for the practicing pulmonologist due to the increase in prevalence of major respiratory disorders as well as the normal changes that occur in sleep patterns with aging. Typically, aging is associated with decreases in the amount of slow wave sleep and increases in stage 1 and 2 non–rapid eye movement sleep, often attributed to an increased number of spontaneous arousals that occur in the elderly. Elderly individuals tend to go to sleep earlier in the evening and wake earlier due to a phase advance in their normal circadian sleep cycle. Furthermore the development of sleep-related respiratory disorders such as obstructive sleep apnea (OSA) and central sleep apnea or Cheyne-Stokes respiration (CSA-CSR) associated with congestive heart failure (CHF) occur with increasing prevalence in the elderly. The development of such disorders is often of major concern because they are associated with systemic hypertension and cardiovascular disease, metabolic disorders such as diabetes, and impaired neurocognition. The present review reﬂects the current understanding of the normal changes in sleep patterns and sleep needs with advancing age, in addition to the effect that aging has on the predisposition to and consequences of OSA and CSA-CSR associated with CHF.
Clinical Aspects of Fatty Liver Disease

The global emergence of obesity as an epidemic has made fatty liver disease a public health problem in the Western world. The increased incidence of obesity has been paralleled by an increase in metabolic syndrome in the same cohort of patients. The net consequence of insulin resistance in a large majority of these obese individuals is hepatic steatosis, which over time in a proportion of these patients progresses to steatohepatitis and cirrhosis. Despite the increased awareness among physicians regarding its presence, the diagnostic process has been hampered by the lack of sensitive and speciﬁc population-based screening tests. Liver biopsy remains the gold standard for diagnosis as well as for grading and staging of the disease process but its precise role in the diagnostic conundrum continues to be debated.
Novel Therapies for Sarcoidosis

The treatment of sarcoidosis remains controversial. Corticosteroids remain the cornerstone of therapy, but immunosuppressive, cytotoxic, and immunomodulatory agents have emerged as viable therapeutic options for patients failing or experiencing adverse effects from corticosteroids. Published data are most extensive with methotrexate, but favorable responses have been noted with leﬂunomide, azathioprine, antimalarial and antimicrobial agents, and tumor necrosis factor-a inhibitors. This review focuses on these novel therapies for sarcoidosis, including indications for use
Reproductive Aging, Sexuality and Symptoms

Female sexual dysfunction (FSD) affects (cid:1) 50% of postmenopausal women. Unfortunately, it often goes undiagnosed because both patients and health-care providers may be reluctant to bring it up at an annual ofﬁce visit. FSD encompasses both physical and emotional components, all of which are often intermingled. Exhaustion, anxiety, stress, interpersonal relationship issues, hormonal changes and their sequelae on vaginal tissue, medication side effects, and medical problems all play a potential role. This review discusses some of the common etiologies and diagnostic and management options.
Heparin-Induced Thrombocytopenia: A Review

Immune heparin-induced thrombocytopenia (HIT) is a relevant adverse drug reaction consisting in a hypercoagulable state caused by an anticoagulant agent. The incidence is (cid:1) 6.5% in patients receiving unfractionated heparin after orthopedic surgery, and is equal to or lower than 1% in other settings. HIT occurrence is a function of heparin type, duration of heparin administration, patient population, and gender. The pathogenesis is due to an antibody response to the complex heparin/platelet factor 4 in most cases, with secondary activation of platelets and coagulation, and ﬁnally increased thrombin generation. Thrombocytopenia, venous or arterial thrombosis, heparin-induced skin necrosis, adrenal hemorrhage, and transient amnesia can characterize the clinical course of HIT. Platelet monitoring in patients receiving heparin is indicated to early detect HIT. A thrombotic event can be the ﬁrst manifestation of HIT. Laboratory demonstration of heparin-dependent platelet activation conﬁrms the clinical diagnosis; antigenic or functional assays are available. Once HIT is highly likely or conﬁrmed serologically, immediate heparin cessation is mandatory and an alternative therapeutic anticoagulant is needed due to the high risk (or the presence) of thrombotic events. The available nonheparin anticoagulants aim to reduce thrombin generation. Lepirudin, argatroban, and bivalirudin (direct thrombin inhibitors) and danaparoid and fondaparinux (factor Xa inhibitors) represent the current treatment options for HIT. Vitamin K antagonists can be used safely only after a stable platelet count has been obtained.
Inhibitors in Hemophilia A: Advances in Elucidation of Inhibitory Mechanisms and in Inhibitor Management with Bypassing Agents

Development of inhibitory antibodies (inhibitors) to factor VIII (FVIII) is the most serious adverse event in replacement therapy of hemophilia A patients. The etiology and management of this condition remain major challenges for both researchers and clinicians. In the present review, we discuss recent advances in understanding the molecular mechanisms by which inhibitors inactivate FVIII and experimental approaches used for the mapping of inhibitor epitopes. We also present a comparative analysis of treatment of hemophilia A patients with inhibitors with currently available bypassing agents—activated prothrombin complex concentrate (FEIBA VH; Baxter Healthcare Corp., Westlake Village, CA) and recombinant activated factor VII (NovoSeven; Novo Nordisk, Princeton, NJ)—and describe some ongoing research programs aimed at developing new treatment options for these patients. Availability of sensitive and standardized laboratory assays that would assist in monitoring the effectiveness of bypass therapies is essential for designing customized treatment regimens and improvement in the management of health conditions of hemophilia patients with inhibitors.
The Role of JAK2 V617F Mutation, Spontaneous Erythropoiesis and Megakaryocytopoiesis, Hypersensitive Platelets, Activated Leukocytes, and Endothelial Cells in the Etiology of Thrombotic Manifestations in Polycythemia Vera and Essential Thrombocythemia

Exaggerated erythropoiesis and megakaryocytopoiesis are present at a variable extent in polycythemia vera (PV) and essential thrombocythemia (ET). With the recent discovery of the V617F mutation in the Janus kinase 2 (JAK2) tyrosine kinase in almost all cases of PV and in a subset of patients with ET, studies are now pending to assess the role of this mutation in the hematopoietic cell activation process and/or in the occurrence of thromboses in ET and PV. The JAK2 V617F point mutation makes the normal hematopoietic progenitor cells hypersensitive to thrombopoietin, erythropoietin, and myeloid progenitor cells, leading to trilinear hematopoietic myeloproliferation. This will have three main clinical consequences during long-term follow-up. First, spontaneous growth of enlarged mature megakaryocytes in ET/PV with overproduction of hypersensitive platelets results in a broad spectrum of platelet-mediated micro-vascular circulatory disturbances, which are very sensitive to low-dose aspirin. Second, spontaneous growth of erythropoiesis with the overproduction of erythrocytes leads to classic PV with increased hemoglobin, hematocrit, and red cell mass. This is associated with a high frequency of major arterial and venous thrombotic complications in addition to platelet-mediated microvascular circulatory disturbances of thrombocythemia. Third, the slowly progressive myeloid (granulocytic) metaplasia in bone marrow and spleen is complicated by secondary myeloﬁbrosis caused by a megakaryocytic
Withdrawal of Life-Sustaining Therapies and Brain Death in the Intensive Care Unit

The majority of patients who die in intensive care units (ICUs), do so as a result of the withdrawal of life-sustaining treatments or as a result of brain death. With the increasing shortage of transplantable organs, there is growing interest in both these patient populations and their potential for organ donation after cardiac death (DCD) or death by neurological criteria. Therefore, it is imperative for neurologists and neurosurgeons to be familiar with both processes when consulted to evaluate these very sick patients in the ICU. The medicolegal and ethical considerations, the factors that lead to the decision for withdrawal (with special attention to prognostication of the major neurological diseases encountered in an ICU), the process of withdrawal of life-sustaining treatment itself, and the DCD process will be examined. The medicolegal aspects of brain death will also be examined, with particular focus on the process and the various pitfalls and misconceptions.
Parameterizing the instrumental spectral response function and its changes by a super-Gaussian and its derivatives

Abstract. The instrumental spectral response function (ISRF) is a key quantity in DOAS analysis, as it is needed for wavelength calibration and for the convolution of trace gas cross sections to instrumental resolution. While it can generally be measured using monochromatic stimuli, it is often parameterized in order to merge different calibration measurements and to plainly account for its wavelength dependency. For some instruments, the ISRF can be described appropriately by a Gaussian function, while for others, dedicated, complex parameterizations with several parameters have been developed. Here we propose to parameterize the ISRF as a super-Gaussian , which can reproduce a variety of shapes, from point-hat to boxcar shape, by just adding one parameter to the classical Gaussian. The super-Gaussian turned out to describe the ISRF of various DOAS instruments well, including the satellite instruments GOME-2, OMI, and TROPOMI. In addition, the super-Gaussian allows for a straightforward parameterization of the effect of ISRF changes, which can occur on long-term scales as well as, for example, during one satellite orbit and impair the spectral analysis if ignored. In order to account for such changes, spectral structures are derived from the derivatives of the super-Gaussian, which are afterwards just scaled during spectral calibration or DOAS analysis. This approach significantly improves the fit quality compared to setups with fixed ISRF, without drawbacks on computation time due to the applied linearization. In addition, the wavelength dependency of the ISRF can be accounted for by accordingly derived spectral structures in an easy, fast, and robust way.
Sleep Disorders and Stroke

Obstructive sleep apnea (OSA) is a very common condition in patients with stroke and is found in over half of stroke patients. There is a complex relationship between OSA and stroke, attributable to shared risk factors. There are numerous mechanisms by which OSA may contribute to increased stroke risk, including promotion of atherosclerosis, hypercoagulability, and adverse effects on cerebral hemodynamics. Obstructive sleep apnea is also a risk factor for hypertension, and likely for atrial ﬁbrillation and diabetes, conditions that in turn are risk factors for stroke. OSA is also associated with poor outcomes following stroke. Further epidemiological studies are needed to assess the relationship between OSA and stroke better. Clinical trials using continuous positive airway pressure as a treatment for OSA in stroke patients are needed to determine whether treatment of this condition alters outcome following stroke.
Neuroimaging of Infections of the Central Nervous System

Neuroimaging plays a crucial role in the diagnosis and therapeutic management of neurologic infections. This article summarizes imaging ﬁndings in brain abscesses, ven-triculitis, viral diseases, and opportunistic infections. In cases of uncomplicated meningitis, cranial computed tomography is sufﬁcient to exclude brain edema, hydrocephalus, and skull base pathology. Magnetic resonance imaging (MRI) is superior in depicting complications (e.g., empyema, vasculitis). Diffusion-weighted imaging (DWI) shows parenchymal complications of meningitis earlier and is of help in differentiation of pyogenic abscess from other ring-enhancing lesions. Proton magnetic resonance spectroscopy can produce speciﬁc peak-patterns in cases of abscess, such as the presence of lactate and cytosolic amino acids. In toxoplasmosis, DWI may help to differentiate from lymphoma, showing no restriction of water diffusion. In patients with viral encephalitis, DWI allows earlier lesion detection. MRI has revolutionized the rapid diagnosis of spinal abscess.
Models of Attention and Dual-Task Performance as Explanatory Constructs in Aphasia

Aphasia has traditionally been viewed as a loss or impairment of language. However, evidence is presented suggesting that language mechanisms are fundamentally preserved and that aphasic language behaviors are instead due to impairments of cognitive processes supporting their construction. These processes may be understood as a linguistically specialized attentional system that is vulnerable to competition from other processing domains. We present two models of attention that focus on competition for central processing and discuss ﬁndings from dual-task studies of normal and aphasic performance. First, competing language and nonlanguage tasks appear to share limited-capacity, parallel processing resources. Second, aphasic individuals demonstrate slowed central processing that could be due to a reduction in processing capacity or ability to allocate that capacity. Third, the attention models discussed bear a coherent relationship to current models of language processing. Clinical implications of a cognitive processing account of aphasia are also considered.
Late Cardiovascular Consequences of Gestational Diabetes Mellitus

Gestational diabetes mellitus (GDM), deﬁned as carbohydrate intolerance of any degree ﬁrst recognized during pregnancy, complicates (cid:1) 4% of all pregnancies in the United States. Several factors can increase one’s risk of developing GDM, including obesity, family history of type 2 diabetes mellitus (T2DM), and race/ethnicity. Conversely, a history of GDM can increase the risk of developing not only T2DM but also cardiovascular disease (CVD) independent of a diagnosis of T2DM. Several investigations have explored GDM relationships with CVD risk factors, CVD surrogate markers, and clinically evident CVD. These studies have included evaluations of biochemical parameters, such as inﬂammatory and endothelial biomarkers; endothelial dysfunction, such as that seen in impaired brachial artery ﬂow-mediated vasodilation; and vascular dysfunction, manifest as cardiac dysfunction or in diseases such as hypertension. This article will review these studies and examine factors considered to be responsible for promoting CVD in women with a history of GDM, such as T2DM and metabolic syndrome and its components. In addition, studies evidencing CVD in women with a history of GDM will be explored.
Lift-induced vortex dipole collapse

Two vortices of opposite sign in two dimensions merely move along parallel lines. We show that even a small buoyancy completely changes this dynamics. When the vortices are of different density from their surroundings, buoyancy produces a lateral drift by Kutta lift. This causes the density patches to merge, and the vortex dipole to collapse. This is followed by a rapid upward (for light vortices) ejection and creation of small-scale structures by baroclinic torque. Our simple analytical equation explains the trajectory of the vortices. We show that these events occur in viscous simulations of many buoyant vortices.
New Strategies for the Treatment of Acute Venous Thromboembolism

In recent years, new opportunities have emerged that have the potential to change rapidly the therapeutic scenario of patients with acute venous thromboembolism (VTE). Selected patients with deep vein thrombosis (DVT) can be treated effectively and safely at home with ﬁxed doses of low molecular weight heparins. The prompt administration of compression elastic stockings in addition to anticoagulant drugs in patients with acute DVT has the potential to halve the rate of late postthrombotic sequelae. The long-term use of low molecular weight heparins is likely to be more effective than oral anticoagulants for the secondary prevention ofVTEinpatientswith advanced malignancy.Patients withpulmonary embolism and right ventricular dysfunction might beneﬁt from the early administration of thrombolytic drugs in combination with heparin to a greater extent than from heparin alone. Despite an impressive amount of clinical information on the proper duration of oral anticoagulants in patients with unprovoked VTE, the optimal long-term treatment of these patients remains undeﬁned. Finally, new categories of drugs are emerging that have the potential to replace conventional anticoagulants in the near future. They include compounds that inhibit factor Xa or thrombin.
Autoantibodies and their Antigens in Autoimmune Hepatitis

Autoantibody detection assists in the diagnosis and allows differentiation of autoimmune hepatitis (AIH) type 1 (AIH-1), characterized by antinuclear antibody (ANA) and/or smooth muscle antibody (SMA), and type 2 (AIH-2), distinguished by the presence of antibodies to liver-kidney microsome type 1 (anti-LKM1) and/or antibodies to liver cytosol type 1 (anti-LC1). Detection of atypical perinuclear antineutrophil cytoplasmic antibodies (pANCA) and anti-soluble liver antigen (SLA) antibodies can act as an additional pointer toward the diagnosis of AIH, particularly in the absence of the conventional autoantibodies. Routine autoantibody testing by indirect immunoﬂuores-cence has been recently complemented by molecular assays based on puriﬁed or recombinant antigens. Although the AIH-1-speciﬁc ANA and SMA targets need better deﬁnition, those of anti-LKM1 and anti-LC1 in AIH-2 have been clearly identiﬁed; the ﬁne speciﬁcity of antibody reactivity and its clinical relevance to disease pathogenesis are the focus of ongoing investigation. This article critically discusses the current knowledge of the diagnostic and clinical signiﬁcance of AIH-related autoantibody reactivities, focusing on key issues that the physician needs to be aware of to be able to request the appropriate testing and to interpret correctly the laboratory results within the clinical context of the patient.